Immunoinflammatory State Detection and Multimodal Brain Imaging and Electrophysiologic Changes in Schizophrenia

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

January 10, 2025

Primary Completion Date

June 1, 2026

Study Completion Date

December 31, 2028

Conditions
SchizophreniaSchizophrenia Spectrum and Other Psychotic DisordersMental Disorders
Interventions
OTHER

Regular follow-up assessments without intervention.

Participants will receive a 3-month follow-up with clinical information, biological samples, and imaging data collected at baseline, 1st and 3rd months. The baseline assessment will include demographic information, medical history and previous medication use. At baseline and follow-up, patients' physical examination data (height, weight, waist and hip circumference, etc.), clinical symptom assessment scales (PANSS, SANS, SAPS, CDSS, CPSS, CGI, GAF, PSP, and SAS) and MCCB cognitive assessment data, blood and cerebrospinal fluid samples, MRI, and EEG data will be collected. Collection and store of blood and cerebrospinal fluid samples for routine laboratory tests and multi-omics including immunohistology, inflammation-related molecules, single-cell sequencing, extracellular vesicles, and other assays.

OTHER

Cross-sectional assessment

Volunteers' physical examination data (height, weight, waist circumference, hip circumference, etc.), scale assessments (SCID, SCL-90, and CPSS) and MCCB cognitive assessment data, blood samples, MRI, and EEG data will be collected. Blood was collected and stored for exploring differences between patients and healthy individuals.

Trial Locations (1)

410011

RECRUITING

Department of Psychiatry, the Second Xiangya Hospital of Central South University, Changsha

All Listed Sponsors
lead

Central South University

OTHER